お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
980665

ブタクサアレルギー治療薬の世界市場:薬剤の種類別・流通チャネル別・地域別 - 市場規模・シェア・予測、新型コロナウイルス感染症 (COVID-19) の影響 (2021年~2027年)

Ragweed Allergy Therapeutics Market with COVID-19 Impact Analysis, By Drug Type, By Distribution Channel, and By Region - Size, Share, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 180 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
ブタクサアレルギー治療薬の世界市場:薬剤の種類別・流通チャネル別・地域別 - 市場規模・シェア・予測、新型コロナウイルス感染症 (COVID-19) の影響 (2021年~2027年)
出版日: 2020年12月01日
発行: AnalystView Market Insights
ページ情報: 英文 180 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のブタクサアレルギー治療薬の市場規模は、2020年には10億6820万米ドルに達し、更に2021年~2027年に5.21%のCAGRで成長する見通しです。市場の主な促進要因として、気候変動の影響や大気汚染の深刻化、最先端の高度治療薬の巨大ニーズなどが挙げられます。地域別では、北米諸国が最大の市場となっています。

当レポートでは、世界のブタクサアレルギー治療薬の市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、薬剤の種類別・流通チャネル別・地域別の市場動向見通し (過去5年間・今後7年間分)、主要企業のプロファイル、新型コロナウイルス感染症 (COVID-19) の影響などを調査しております。

目次

第1章 ブタクサアレルギー治療薬:市場概要

第2章 エグゼクティブサマリー

第3章 ブタクサアレルギー治療薬市場:主な市場動向

  • 市場促進要因
    • 市場促進要因の影響度の分析
  • 市場抑制要因
    • 市場抑制要因の影響度の分析
  • 市場機会
  • 将来の市場動向

第4章 ブタクサアレルギー治療薬市場:産業研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 市場成長の見通し:マッピング
  • 規制体制の分析

第5章 ブタクサアレルギー治療薬市場:新型コロナウイルス感染症 (COVID-19) の影響分析

  • 「コロナ以前」の影響分析
  • 「コロナ以降」の影響分析
    • 高業績セグメント
    • 限界成長セグメント
    • 低業績セグメント
    • 限界損失セグメント

第6章 ブタクサアレルギー治療薬市場:市場環境

  • 市場シェア分析 (2019年)
  • 主な技術革新企業 (イノベーター) の分析
  • 市場区分データ:主要メーカー別
    • 既存企業の分析
    • 新規企業の分析

第6章 ブタクサアレルギー治療薬市場:薬剤の種類別

  • 概要
  • 抗ヒスタミン薬
  • 経鼻コルチコステロイド
  • 充血緩和薬
  • 遺伝子組換え薬
  • その他

第8章 ブタクサアレルギー治療薬市場:流通チャネル別

  • 概要
  • 病院薬局
  • 小売薬局
  • オンライン

第9章 ブタクサアレルギー治療薬市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル
    • Anergis SA
    • ALK-Abello A/S
    • Biomay AG
    • Astellas Pharma Inc.
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare Private Limited
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical, Inc.
    • Alcon
    • Stallergenes Greer
    • bioMerieux SA
    • Lincoln Diagnostics, Inc.
    • HOB Biotech Group Corp Ltd.
    • Hitachi Chemical Diagnostics, Inc.
    • Novartis AG
    • Immunomic Therapeutics, Inc.

第11章 アナリストの全方位的分析

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Ragweed Allergy Therapeutics market: Drug Types Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Types
  • TABLE Global Ragweed Allergy Therapeutics market, by Drug Types 2016-2027 (USD Million)
  • TABLE Ragweed Allergy Therapeutics market: Application Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Ragweed Allergy Therapeutics market, by Application 2016-2027 (USD Million)
  • TABLE Ragweed Allergy Therapeutics market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Ragweed Allergy Therapeutics market, by Region 2016-2027 (USD Million)
  • TABLE North America Ragweed Allergy Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE North America Ragweed Allergy Therapeutics market, by Drug Types, 2016-2027 (USD Million)
  • TABLE North America Ragweed Allergy Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Europe Ragweed Allergy Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Ragweed Allergy Therapeutics market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Europe Ragweed Allergy Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Ragweed Allergy Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Ragweed Allergy Therapeutics market, by Drug Types, 2016-2027 (USD Million)
  • TABLE Asia Pacific Ragweed Allergy Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Ragweed Allergy Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Ragweed Allergy Therapeutics market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Latin America Ragweed Allergy Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Ragweed Allergy Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Ragweed Allergy Therapeutics market, by Drug Type, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Ragweed Allergy Therapeutics market, by Application, 2016-2027 (USD Million)

List of Figures

  • FIGURE Ragweed Allergy Therapeutics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Drug Type segment market share analysis, 2020 & 2027
  • FIGURE Drug Type segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Application segment market share analysis, 2020 & 2027
  • FIGURE Application segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Ragweed Allergy Therapeutics market share and leading players, 2019
  • FIGURE Europe Ragweed Allergy Therapeutics market share and leading players, 2019
  • FIGURE Asia Pacific Ragweed Allergy Therapeutics market share and leading players, 2019
  • FIGURE Latin America Ragweed Allergy Therapeutics market share and leading players, 2019
  • FIGURE Middle East and Africa Ragweed Allergy Therapeutics market share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Ragweed Allergy Therapeutics market share analysis by country, 2019
  • FIGURE Germany Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Ragweed Allergy Therapeutics market share analysis by country, 2019
  • FIGURE India Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Ragweed Allergy Therapeutics market share analysis by country, 2019
  • FIGURE Brazil Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Ragweed Allergy Therapeutics market share analysis by country, 2019
  • FIGURE Saudi Arabia Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Ragweed Allergy Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

REPORT HIGHLIGHT

The global Ragweed Allergy Therapeutics market was valued at USD 1,068.2 million in 2020, growing with 5.21% CAGR during the forecast period, 2021-2027.

Ragweed is a kind of flowering plant that originates from the genus Ambrosia in the aster family. Ragweed allergy occurs when our human immune system shows an inappropriate response. The immune system helps to fight against bacteria and viruses. The allergies caused by the ragweed can be treated with medications and antihistamines.

The ragweed allergy therapeutics market is estimated to witness significant growth in the next few years. The growing demand for advanced therapies for ragweed allergy treatment is mainly contributing to market growth. Additionally, changes in environmental conditions and expanding pollution are leading to the growth of ragweed allergy therapeutic treatment. According to the Asthma & Allergy Foundation of America (AAFA), over 23 million population in the U.S. have shown symptoms of ragweed pollen allergies in the late summers. Such symptoms make life miserable for those with allergies that cause asthma symptoms for allergic asthma individuals.

According to a research study, climatic changes tend to cause ragweed allergy and impact a larger population across the world. For example, based on data from the American College of Allergy, there are over 17 species of ragweeds present in the U.S. these allergies can be treated with proper therapeutics treatment. In addition, several companies are increasing their focus on clinical trials, strategic partnerships, and spending on R&D developments of advanced drugs, & other novel therapies. The drug authorizations and strategic collaborative research are anticipated to significantly offer ample growth opportunities for the market.

North America held the largest market share in 2019. Key players are focusing on getting product approvals & clinical trials of drugs for treating ragweed allergies. For example, the U.S. Food and Drug Administration (FDA) has granted two novel prescription medications, Grastek, and Ragwitek for the treatment of ragweed allergies. All these initiatives are anticipated to boost regional growth. a significant rate over the forecast period. The European market is expected to foresee significant growth due to initiatives taken by key companies for the treatment of ragweed allergy. For example, in Europe, ALK has submitted a registration for 'Ragweed SLIT-tablet' in 2017.

The ragweed allergy therapeutics market is moderately competitive in nature with the presence of international and local players. Key players in the market engage in strategic collaboration, and R&D activities to remain competitive in the industry. For example, Austria-based biotech companies, VTU Technology, and Biomay AG collaborate to produce recombinant allergens.

Key features of the study:

This proposed research study on Ragweed Allergy Therapeutics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Ragweed Allergy Therapeutics market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Ragweed Allergy Therapeutics market

Impact of COVID-19 on Ragweed Allergy Therapeutics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Ragweed Allergy Therapeutics market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Ragweed Allergy Therapeutics market, we have also included competitive landscape and key innovator analysis for the Ragweed Allergy Therapeutics market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Ragweed Allergy Therapeutics market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Ragweed Allergy Therapeutics market on global as well as regional level.

The global Ragweed Allergy Therapeutics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RAGWEED ALLERGY THERAPEUTICS MARKET KEY PLAYERS

Anergis SA

ALK-Abello A/S

Biomay AG

Astellas Pharma Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare Private Limited

Omega Diagnostics Group PLC

HYCOR Biomedical, Inc.

Alcon

Stallergenes Greer

bioMerieux SA

Lincoln Diagnostics, Inc.

HOB Biotech Group Corp Ltd.

Hitachi Chemical Diagnostics, Inc.

Novartis AG

Immunomic Therapeutics, Inc.

GLOBAL RAGWEED ALLERGY THERAPEUTICS MARKET, BY DRUG TYPE

Antihistamines

Nasal Corticosteroids

Decongestants

Recombinant Drugs

Others

GLOBAL RAGWEED ALLERGY THERAPEUTICS MARKET, BY DISTRIBUTRION CHANNEL

Hospital Pharmacy

Retail Pharmacy

Online

GLOBAL RAGWEED ALLERGY THERAPEUTICS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Ragweed Allergy Therapeutics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Drug Type
    • 2.1.2. Market Snippet by Distribution Channel
    • 2.1.3. Market Snippet by Region
  • 2.2. Competitive Insights

3. Ragweed Allergy Therapeutics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Ragweed Allergy Therapeutics Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Ragweed Allergy Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Ragweed Allergy Therapeutics Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Ragweed Allergy Therapeutics Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2020 & 2027 (%)
  • 7.2. Antihistamines
  • 7.3. Nasal Corticosteroids
  • 7.4. Decongestants
  • 7.5. Recombinant Drugs
  • 7.6. Others

8. Ragweed Allergy Therapeutics Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Online

9. Ragweed Allergy Therapeutics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.3.10. Rest of Europe
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.3.10.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.3.10.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.4.10. Rest of APAC
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.4.10.3. Rest of APAC Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.4.10.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.5.9. Rest of LATAM
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.5.9.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.5.9.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2016 - 2027 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)

10. Key Vendor Analysis

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Anergis SA
    • 10.2.2. ALK-Abello A/S
    • 10.2.3. Biomay AG
    • 10.2.4. Astellas Pharma Inc.
    • 10.2.5. Thermo Fisher Scientific Inc.
    • 10.2.6. Siemens Healthcare Private Limited
    • 10.2.7. Omega Diagnostics Group PLC
    • 10.2.8. HYCOR Biomedical, Inc.
    • 10.2.9. Alcon
    • 10.2.10. Stallergenes Greer
    • 10.2.11. bioMerieux SA
    • 10.2.12. Lincoln Diagnostics, Inc.
    • 10.2.13. HOB Biotech Group Corp Ltd.
    • 10.2.14. Hitachi Chemical Diagnostics, Inc.
    • 10.2.15. Novartis AG
    • 10.2.16. Immunomic Therapeutics, Inc.

11. 360 Degree AnalystView

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.